Meluzio Michael Vincent bought CUE
July 9, 2026 · Form 4 insider transaction
Meluzio Michael Vincent bought 40,942 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
40,942
Price
$0.00
Total value
N/A
InsiderMeluzio Michael Vincent
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 9, 2026
Filing dateJuly 10, 2026
Shares owned after40,942
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents that grant of restricted stock units ("RSUs"). The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date.